![Christopher R. Seaton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher R. Seaton
Chairman at Middlesex Hospital
Christopher R. Seaton active positions
Companies | Position | Start | End |
---|---|---|---|
Middlesex Hospital
![]() Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family. | Chairman | 2010-04-18 | - |
Versantis AG
![]() Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Director/Board Member | 2021-02-04 | - |
Career history of Christopher R. Seaton
Training of Christopher R. Seaton
McMaster University | Masters Business Admin |
Statistics
International
United States | 2 |
Canada | 2 |
Switzerland | 2 |
Operational
Chairman | 1 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Middlesex Hospital
![]() Middlesex Hospital Hospital/Nursing ManagementHealth Services Middlesex Hospital, located in Middletown, CT, provides healthcare services to patients and families. The hospital prides itself on providing quality care and treating patients like family. | Health Services |
Versantis AG
![]() Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |